Source:http://linkedlifedata.com/resource/pubmed/id/21623866
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2011-7-18
|
pubmed:abstractText |
CD20 is a transmembrane protein that is expressed by B cells during their development and is, therefore, commonly used to label cells of B lineage in lymphoid infiltrates. CD20-positive T-cell lymphoma is infrequent but well recognized. Cases reported in the literature show a variety of clinical and histoimmunochemical profiles. Primary cutaneous CD20-positive T-cell lymphoma is vanishingly rare; only eight cases have been previously reported. We present two new cases of this entity and describe their clinical, histological and immunohistochemical features. CD20 is a highly specific B-cell marker. However, it has been reported in a subset of normal T-cells in peripheral blood and bone marrow of healthy individuals. This subset of T-cells also expresses more often CD8 and g/d than the CD20-negative T-cells. Two main theories have been postulated to explain the expression of CD20 by neoplastic T-cells. The first possibility is that these lymphomas develop from the CD20-positive subset of normal T-cells. The second theory regards CD20 as an activation marker. Prognostic implications and therapeutic options of T-cell lymphomas with positivity for CD20 remain to be elucidated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1600-0560
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2011 John Wiley & Sons A/S.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
663-9
|
pubmed:meshHeading |
pubmed-meshheading:21623866-Aged, 80 and over,
pubmed-meshheading:21623866-Antigens, CD20,
pubmed-meshheading:21623866-Antigens, CD8,
pubmed-meshheading:21623866-B-Lymphocytes,
pubmed-meshheading:21623866-Humans,
pubmed-meshheading:21623866-Lymphoma, T-Cell, Cutaneous,
pubmed-meshheading:21623866-Male,
pubmed-meshheading:21623866-Middle Aged,
pubmed-meshheading:21623866-Skin Neoplasms,
pubmed-meshheading:21623866-T-Lymphocytes,
pubmed-meshheading:21623866-Tumor Markers, Biological
|
pubmed:year |
2011
|
pubmed:articleTitle |
Primary cutaneous CD20-positive T-cell lymphoma.
|
pubmed:affiliation |
Department of Dermatopathology, St John's Institute of Dermatology, St Thomas Hospital, London, UK. blancamartin@hotmail.com
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports
|